Characterization of a single reporter-gene potency assay for T-cell-dependent bispecific molecules

ABSTRACTT-cell-dependent bispecific antibodies (TDBs) are promising cancer immunotherapies that recruit patients’ T cells to kill cancer cells. There are many TDBs in clinical trials, demonstrating...